Centre plans central licensing for sterile drugs
Headline by Prism · from 1 report
The Indian government plans to shift licensing for sterile drug products to a central authority to address quality discrepancies.
Telangana TodayThe brief
Written by software from the 1 report below.
- The Indian government intends to move the licensing of sterile medicines from state authorities to a unified central system.
- This decision follows the discovery of approximately 240 substandard injection samples during the 2026 fiscal year.
- Inconsistencies in enforcement and quality testing between states led to significant regulatory concerns.
- Centralized oversight aims to enforce uniform safety standards for high-risk medications across all manufacturing facilities.
What to watch next
- Formal amendments to the Drugs Rules 1945
- Transition of sterile drug licensing to the Central License Approving Authority
The points restate the reports; where one says why it matters, that is Prism's reading, not a reported fact.
Coverage
1 outlet
All filed from India
NamedIndia · Hyderabad · Telangana Drug Control Administration · Central Drug Standards Control Organisation · Central License Approving Authority
The 1 report is listed beside the record.
Corrections and versions
A correction says what was wrong and why. Every earlier headline and brief of this record is kept.
Something wrong?
Say what, and it arrives with this record's address filled in. A correction is welcome.
Ask this story
Answers cite the 1 report above, or say they can't.